Profile data is unavailable for this security.
About the company
Scorpius Holdings, Inc. is a contract development and manufacturing organization (CDMO) that provides process development and biomanufacturing services to support the biomanufacturing needs of third parties who use its biomanufacturing capacity as a fee-for-service model through its subsidiary, Scorpius Biomanufacturing, Inc. The Company couples Current Good Manufacturing Practices (CGMP) biomanufacturing and quality control knowledge with capabilities in immunoassays, molecular assays, and bioanalytical methods to support cell- and gene-based therapies as well as large molecule biologics using American-made equipment, reagents, and materials. It offers an array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. The Company's CDMO service offerings also include enhanced microbial and mammalian development and manufacturing services.
- Revenue in USD (TTM)10.04m
- Net income in USD-29.66m
- Incorporated2008
- Employees82.00
- LocationScorpius Holdings Inc627 DAVIS DRIVE, SUITE 300MORRISVILLE 27560United StatesUSA
- Phone+1 (919) 240-7133
- Fax+1 (302) 636-5454
- Websitehttps://www.nighthawkbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cbdMD Inc | 20.64m | -23.42m | 1.73m | 52.00 | -- | 0.5725 | -- | 0.084 | -18.95 | -18.95 | 7.85 | 0.8055 | 0.8817 | 2.01 | 20.35 | 396,856.90 | -82.98 | -38.59 | -112.36 | -41.50 | 63.43 | 63.80 | -94.12 | -87.98 | 0.5172 | -3.89 | 0.3128 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
| SOHM Inc | -100.00bn | -100.00bn | 1.82m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| InVitro International | 716.89k | 6.22k | 1.82m | 16.00 | 228.57 | 2.49 | -- | 2.54 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
| PainReform Ltd | 0.00 | -17.67m | 1.89m | 6.00 | -- | -- | -- | -- | -167.66 | -167.66 | 0.00 | -14.12 | 0.00 | -- | -- | 0.00 | -309.43 | -55.47 | -650.22 | -68.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -6.28 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.08m | 40.00 | -- | -- | -- | 0.7511 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| CYANOTECH CORP | 23.30m | -5.45m | 2.65m | 77.00 | -- | 0.2727 | -- | 0.1137 | -0.7939 | -0.7939 | 3.40 | 1.36 | 0.896 | 2.15 | 15.42 | 302,532.50 | -20.98 | -3.46 | -32.30 | -4.46 | 22.66 | 34.54 | -23.41 | -3.58 | 0.307 | -7.00 | 0.42 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
| Universe Pharmaceuticals Inc | 26.73m | -18.55m | 2.82m | 225.00 | -- | 0.0163 | -- | 0.1056 | -76.44 | -76.44 | 110.26 | 110.02 | 0.4462 | 6.13 | 1.68 | 118,781.90 | -30.97 | 5.31 | -48.85 | 7.07 | 28.27 | 46.26 | -69.40 | 6.25 | 1.46 | -0.6939 | 0.1958 | 0.00 | -19.52 | 2.53 | 29.46 | -- | -21.17 | -- |
| Scorpius Holdings Inc | 10.04m | -29.66m | 2.86m | 82.00 | -- | 0.0813 | -- | 0.2846 | -107.62 | -101.17 | 5.25 | 8.12 | 0.1725 | -- | 16.55 | 122,491.30 | -53.23 | -39.37 | -69.92 | -43.18 | 61.92 | -- | -308.58 | -1,068.21 | 0.6007 | -27.31 | 0.3146 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Processa Pharmaceuticals Inc | 0.00 | -11.53m | 2.87m | 13.00 | -- | 0.7727 | -- | -- | -4.86 | -4.86 | 0.00 | 1.14 | 0.00 | -- | -- | 0.00 | -176.99 | -84.35 | -209.96 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0022 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 2.98m | -- | -- | -- | 1.97 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Scisparc Ltd | 0.00 | -6.96m | 2.99m | 3.00 | -- | 8.40 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
| China Pharma Holdings Inc | 5.54m | -4.74m | 3.42m | 231.00 | -- | 0.5444 | -- | 0.616 | -0.3958 | -0.3958 | 0.4119 | 0.3655 | 0.3848 | 2.38 | 15.81 | 24,002.68 | -32.92 | -29.66 | -55.81 | -55.25 | -34.34 | 6.47 | -85.56 | -73.09 | 0.2605 | -27.44 | 0.377 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
| NovaBay Pharmaceuticals Inc | 11.20m | -16.44m | 3.52m | 24.00 | -- | 3.30 | -- | 0.314 | -53.22 | -53.40 | 7.77 | 0.2195 | 1.34 | 2.22 | 13.83 | 466,625.00 | -119.49 | -61.51 | -196.48 | -83.89 | 60.67 | 59.99 | -89.25 | -86.47 | 0.9103 | -- | 0.0454 | -- | 2.24 | 3.32 | -2.66 | -- | -15.46 | -- |
| Titan Pharmaceuticals Inc | 4.00k | -5.46m | 3.59m | 4.00 | -- | 0.8998 | -- | 898.23 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Sonoma Pharmaceuticals Inc | 13.55m | -3.69m | 3.90m | 172.00 | -- | 0.7278 | -- | 0.2877 | -4.91 | -4.91 | 16.95 | 4.00 | 0.9917 | 3.11 | 5.04 | 78,761.63 | -26.98 | -29.36 | -35.49 | -40.65 | 38.52 | 38.00 | -27.21 | -30.93 | 2.84 | -- | 0.0151 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
Data as of Nov 22 2024. Currency figures normalised to Scorpius Holdings Inc's reporting currency: US Dollar USD
24.60%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sabby Management LLCas of 30 Sep 2024 | 346.26k | 11.11% |
| 3i Management LLCas of 26 Sep 2024 | 146.99k | 4.72% |
| Warberg Asset Management LLCas of 30 Sep 2024 | 95.00k | 3.05% |
| Altium Capital Management LPas of 30 Sep 2024 | 88.29k | 2.83% |
| HRT Financial LP (US)as of 30 Sep 2024 | 51.60k | 1.66% |
| UBS Securities LLCas of 30 Sep 2024 | 19.29k | 0.62% |
| Geode Capital Management LLCas of 30 Sep 2024 | 15.90k | 0.51% |
| Group One Trading LLCas of 30 Sep 2024 | 2.97k | 0.10% |
| Morgan Stanley & Co. LLCas of 30 Sep 2024 | 133.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Sep 2024 | 23.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 22 Oct 2024Source: FactSet Research Systems Inc.
